<qa>  What is the purpose of this study?The purpose of this study is to assess the safety, tolerability, and efficacy of sofosbuvir GS-7977; PSI-7977 administered in combination with pegylated interferon and ribavirin PEGRBV in treatment-naive patients with HCV genotypes 1,4,5,6, or indeterminate genotype. 